The effect of olanzapine pretreatment on acute cocaine toxicity in mice

Clinical Toxicology

Volumn 47, Issue 6, 2009, Pages 542-544

  Heard, Kennon J ^a   Cleveland, Nathan R ^b   Krier, Shay ^c  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Antipsychotic; Cocaine; Overdose

Indexed keywords

COCAINE; OLANZAPINE; SODIUM CHLORIDE; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; VASOCONSTRICTOR AGENT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; MORTALITY; MOUSE; NONHUMAN; SEIZURE; ANIMAL; CHEMICALLY INDUCED DISORDER; COCAINE DEPENDENCE; DISEASE MODEL; DRUG ANTAGONISM; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; LONGEVITY; MOUSE STRAIN; PATHOPHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; BENZODIAZEPINES; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DRUG ANTAGONISM; INJECTIONS, INTRAPERITONEAL; LONGEVITY; MALE; MICE; MICE, INBRED STRAINS; POISONING; SEIZURES; SEROTONIN UPTAKE INHIBITORS; VASOCONSTRICTOR AGENTS;

EID: 67651146923     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650902973675     Document Type: Article

References (15)

1. Ritz MC, George FR. Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology (Berl) 1997; 129:311-321.
2. Ritz MC, George FR. Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology (Berl) 1997; 129:299-310.
3. Ritz MC, George FR. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 1993; 264:1333-1343.
4. Derlet RW, Albertson TE. Diazepam in the prevention of seizures and death in cocaine-intoxicated rats. Ann Emerg Med 1989; 18:542-546.
5. Schmidt AW, Lebel LA, Howard HR Jr, Zorn SH. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001; 425:197-201.
6. Visalli T, Turkall R, Abdel-Rahman MS. Gender differences in cocaine pharmacokinetics in CF-1 mice. Toxicol Lett 2005; 155:35-40. (Pubitemid 39600734)
7. Acute Oral Toxicity (AOT). Up-And-Down-Procedure: United States Environmental Protection Agency. http://www.epa.gov/oppfead1/ harmonization/. Accessed 11 August 2008.
8. Cleveland NR, Krier S, Heard K. Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model. Acad Emerg Med 2007; 14:691-694.
9. Derlet RW, Albertson TE, Rice P. The effect of haloperidol in cocaine and amphetamine intoxication. J Emerg Med 1989; 7:633-637.
10. Derlet RW, Albertson TE, Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 1990; 36:745-749.
11. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE. Risperidone compared with new and antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996; 124:57-73.
12. Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila) 2008; 46:1-10.
13. Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 2003; 97:181-222.
14. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14:87-96.
15. Dose Calculator: United States Food and Drug Administration. http://www. accessdata.fda.gov/scripts/cder/onctools/animalresults.cfm. Accessed 11 August 2008.